We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

No more fears

22 June 2005 By Robert Cyran

Guidant shares fell to a 10% discount to Johnson & Johnson s offer price after the medical devices group offered to replace heart implants. But the deal is likely to go ahead as planned. Replacements aren t typically expensive unlike the deal s $750m break fee.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)